Search results
Results From The WOW.Com Content Network
Computational and Structural Biotechnology Journal; Computational Biology and Chemistry; Computers in Biology and Medicine; Current Bioinformatics; Database; EMBnet.journal; Evolutionary Bioinformatics; GigaScience; IEEE/ACM Transactions on Computational Biology and Bioinformatics; Journal of the American Medical Informatics Association
Impact factor. 3.5 (2023) ... BMC Biotechnology is a peer-reviewed open-access scientific journal that covers the field of ... the journal has a 2023 impact factor of ...
Abiogenesis; Aerobiology; Agronomy; Agrostology; Anatomy; Astrobiology; Bacteriology; Biochemistry; Biogeography; Biogeology; Bioinformatics; Biological engineering
Impact factor 2022 [1] Website Trends in Biochemical Sciences: Trends Biochem. Sci. Biochemistry: Sannie Culbertson 1976 13.8 Trends in Biotechnology: Trends Biotechnol. Biotechnology: Matthew Pavlovich 1983 17.8 Trends in Cancer: Trends Cancer: Oncology: Danielle Loughlin 2015 18.4 Trends in Cell Biology: Trends Cell Biol. Cell biology: Ilaria ...
According to the Journal Citation Reports, the journal has a 2021 impact factor of 13.263, ranking it 5th out of 238 journals in the category "Plant Sciences" [1] and 8th out of 158 journals in the category "Biotechnology & Applied Microbiology". [2] As an Open Access journal, articles are accessible globally without restriction.
Download as PDF; Printable version; ... Pages in category "Biotechnology journals" ... Current Opinion in Biotechnology; Current Trends in Biotechnology and Pharmacy; E.
Nature Biotechnology is a monthly peer-reviewed scientific journal published by Nature Portfolio. The editor-in-chief is Barbara Cheifet who heads an in-house team of editors. [ 1 ] The focus of the journal is biotechnology including research results and the commercial business sector of this field.
The journal was established in 1979 under the title Journal of Applied Biochemistry by Academic Press, obtaining its present title in 1986. [1]Former editors-in-chief include Peter Campbell (University College London; before 1996), Roger Lundblad (formerly of Baxter Biotech, Duarte, California; 1996–2002), and Parviz A. Shamlou (Eli Lilly; 2003–2012).